Mortality from Percutaneous Nephrolithotomy: A Systematic Review from European Association of Urology Endourology
European Urology Focus · 2026-06 · 12 (3) · 539-549
DOI: 10.1016/j.euf.2026.01.004 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Urology Focus, 2026-06. Verfasst von Nicholas L Harrison und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool University Hospitals, Liverpool, UK. Electronic address: n.harrison@doctors.org.uk. Hauptthemen laut MEDLINE: Nephrolithotomy, Percutaneous, Kidney Calculi. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Percutaneous nephrolithotomy (PCNL) is a common urological procedure recommended as first-line treatment for large renal calculi. This systematic review aimed to determine the mortality associated with PCNL in managing kidney stone disease (KSD). METHODS: In line with the Preferred Reporting Items for Systematic reviews and Meta-analyses guidelines, a literature search was conducted across Medline, Embase, CINAHL, and the Cochrane Library. The inclusion criteria included English articles of adult and paediatric patients that reported on mortality from PCNL. The extracted data included patient demographics, comorbidities, number of mortalities, and cause of mortality. KEY FINDINGS AND LIMITATIONS: Sixty-five articles were included, which reported on 634 844 patients over a time period spanning from 1983 to 2024. A total of 2777 mortalities were identified. The overall weighted proportion mortality rate for adult studies, excluding selected patient cohorts, was 0.24%. The overall weighted proportion paediatric mortality rate was 0.6%, and mortality rates for other specific patient subgroups varied. Where the cause of death was reported, the most common causes of death in patients were sepsis (35.6%), myocardial infarction (23.3%), haemorrhage (12.2%), and pulmonary embolism (11.1%). CONCLUSIONS AND CLINICAL IMPLICATIONS: Mortality rates from PCNL have remained stable and low over the lifetime of the procedure, with a slight reduction in reported mortality rates over time, despite increasing prevalence of KSD and patient comorbidities. Reporting of mortalities from PCNL has increased in recent years, with the most common causes of mortality identified being sepsis, myocardial infarction, and haemorrhage. Careful patient selection, with the identification and mitigation of risk factors, is vital in reducing the risk of mortality from PCNL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liverpool University Hospitals, Liverpool, UK. Electronic address: n.harrison@doctors.org.uk.
- University Hospital Southampton NHS Trust, Southampton, UK.
- Liverpool University Hospitals, Liverpool, UK.
- University of Athens, Athens, Greece.
- Manipal University of Higher Education (MAHE), Manipal, Karnataka, India.
- University of Patras, Patras, Greece; European School of Urology, Arnhem, The Netherlands.
Zitieren
APA
Harrison, N. L., Dassanayake, S. N., Heppenstall-Harris, G. Z., Skolarikos, A., Chawla, A., Liatsikos, E., Zeng, G., Tsaturyan, A., Tokas, T., Guven, S., & Somani, B. K. (2026). Mortality from Percutaneous Nephrolithotomy: A Systematic Review from European Association of Urology Endourology. European Urology Focus, 12(3), 539-549. https://doi.org/10.1016/j.euf.2026.01.004
Vancouver
Harrison NL, Dassanayake SN, Heppenstall-Harris GZ, Skolarikos A, Chawla A, Liatsikos E, et al. Mortality from Percutaneous Nephrolithotomy: A Systematic Review from European Association of Urology Endourology. European Urology Focus. 2026;12(3):539-549. doi:10.1016/j.euf.2026.01.004
BibTeX
@article{Harrison2026,
author = {Harrison, Nicholas L and Dassanayake, Sohani N and Heppenstall-Harris, Gabriel Z and Skolarikos, Andreas and Chawla, Arun and Liatsikos, Evangelos and Zeng, Guohua and Tsaturyan, Arman and Tokas, Theodoros and Guven, Selcuk and Somani, Bhaskar K},
title = {Mortality from Percutaneous Nephrolithotomy: A Systematic Review from European Association of Urology Endourology},
journal = {European Urology Focus},
year = {2026},
volume = {12},
number = {3},
pages = {539--549},
doi = {10.1016/j.euf.2026.01.004}
}
EUVIMED